Lexmark International Inc. (NYSE:LXK): According to Deutsche Bank, Lexmark will have a short-term earnings lift from the loss of its inkjet operations, but its medium term growth prospects are damaged. Also, its multiple will continue to be under pressure. The firm gives shares a Hold rating and a $18 price target on the stock.
Don’t Miss: Where is RIM on BlackBerry 10 Launch?
Verizon Communications Inc. (NYSE:VZ): Following, the federal government’s approval of Verizon’s purchase of spectrum from cable companies, Argus thinks that the deal could ensure that the company is able to meet wireless data demand in upcoming years. The firm argues that AT&T (NYSE:T) will not possess similar capabilities, and it still to identifies Verizon as a Focus List selection.
Veeco Instruments Inc. (NASDAQ:VECO): Veeco mentioned positively at UBS
Veeco Instruments Inc. (NASDAQ:VECO) was mentioned positively by UBS. The firm’s checks also suggest that HC Smitek’s new LED fab could utilize 12 units of Veeco’s 4 chamber MaxBright tool, with more orders to following. The firm thinks that HC Semitek may add 51c to the EPS of Veeco through the next three years. Shares have a Buy rating and a $40 price target.
Abbott Laboratories (NYSE:ABT): Wells Fargo has mentioned that earlier in the day, the FDA’s Gastroenterology and Urology Devices Panel voted 15-2 that the benefits of Abbott’s Humira’s outweigh the risks for treatment for moderate to severe ulcerative colitis and recommended that the new indication be approved. The firm predicts that the indication may add nearly $200 million to U.S. Humira sales and is a modest positive for Abbott. Wells keeps a Market Perform rating on the stock.
Don’t Miss: Are Home Prices Finding Support?
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.